Damon Michaels, chief operating officer of emerging biotech and life sciences company Mydecine sat down with The Dales Report last week to discuss the company’s latest activity.
Articles
MINDCURE (CSE: MCUR) (OTCQB: MCURF) Receives Unconditional Ethics Approval for its Psychedelic Integration Protocol Research Study
This approval is a key step forward in the development of the company's iSTRYM digital therapeutics platform
New York Lawmaker Files Bill To Decriminalize Psilocybin Mushrooms
A New York lawmaker is proposing to decriminalize psychedelic mushrooms in the state.
MindMed Announces C$19.5 Million Bought Deal Private Placement Offering
MindMed raises CAD$19.5 million selling units at CAD$3.25.
Biden’s USDA Secretary Gives Final Approval To Hemp Rules Despite Ongoing Industry Concerns
The newly confirmed head of the U.S. Department of Agriculture (USDA) has given final approval to a federal rule laying out regulations for the hemp industry, despite outstanding concerns from advocates about certain provisions.
Previous antidepressant use may blunt the effectiveness of MDMA-assisted psychotherapy for PTSD
New research suggests that MDMA-assisted therapy for the treatment of posttraumatic stress disorder (PTSD) is less effective among those who have recently used selective serotonin reuptake inhibitors (SSRIs), a common psychiatric medication.
The Race to Patent Psychedelics Is Just Getting Started
The author and podcast host Tim Ferriss has done his share of heavy lifting when it comes to supporting and promoting research on psychedelic drugs.
Local Activists In Washington State Push For Psilocybin Decriminalization
Voters in Spokane, Washington could make the city one of the latest to decriminalize psilocybin mushrooms under a proposed ordinance that was recently filed by local activists.
Veterans Groups Want Marijuana And Psychedelics Access Through VA, They Tell Congress
Leaders of military veterans organizations sent a clear message to congressional lawmakers this week: federal marijuana and psychedelics laws are outdated and should be reformed to give service members alternative treatment options for conditions like post-traumatic stress disorder.
New Research Finds Marijuana Use Not Associated With Hypertension
A study from an international team of researchers has found that current or past use of marijuana is not independently associated with an increased risk of hypertension.
MagicMed Industries Announces Collaboration with Artificial Intelligence Thought Leaders and the Launch of PsyAI™
MagicMed Industries announces an R&D partnership for the development of PsyAI(TM), a an AI-based tool to "modernize psychedelic medicine."
MINDCURE Discovers Potential Opportunity for Ibogaine-Assisted Psychotherapy to Treat Neuropathic Pain and Traumatic Brain Injury
This potential treatment opportunity was confirmed by the company's bioinformatics platform, PsyCollage
Other Psychedelic Stocks Get Cheaper As atai Gets More Expensive
If atai Life Sciences trades in the expected manner off its IPO, its market cap will quickly exceed the COMBINED market caps of all other psychedelic stocks.
Alabama Senate Panel Passes Bill To End Jail Time For Pot Possession
An Alabama legislative committee approved a bill on Wednesday that would eliminate jail time as a punishment for marijuana possession offenses.
Iowa Lawmakers Hold Historic Hearing On Psilocybin Decriminalization, But Do Not Advance Bill
In a first-of-its kind hearing, an Iowa House panel on Wednesday took up a bill to decriminalize psilocybin mushrooms in the state.